‘Madness’ if Sandoz entitled to generic Lexapro licence, High Court told

Appeals 2021-10-12 7:20 pm By Cindy Cameronne | Sydney

Please login to bookmark

Danish drug maker Lundbeck has told the High Court it did not contract away a royalty-free licence to generic drug maker Sandoz to sell blockbuster antidepressant Lexapro, saying such a decision would be commercial “madness”.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au